A detailed history of Groesbeck Investment Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Groesbeck Investment Management Corp holds 2,804 shares of AMGN stock, worth $741,629. This represents 1.33% of its overall portfolio holdings.

Number of Shares
2,804
Previous 3,404 17.63%
Holding current value
$741,629
Previous $1.06 Million 15.13%
% of portfolio
1.33%
Previous 1.47%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$309.38 - $337.38 $185,628 - $202,428
-600 Reduced 17.63%
2,804 $903,000
Q2 2024

Jul 26, 2024

SELL
$262.75 - $319.31 $104,837 - $127,404
-399 Reduced 10.49%
3,404 $1.06 Million
Q1 2024

Apr 29, 2024

BUY
$268.87 - $324.56 $4,033 - $4,868
15 Added 0.4%
3,803 $1.08 Million
Q4 2023

Jan 31, 2024

BUY
$255.7 - $288.46 $51,140 - $57,691
200 Added 5.57%
3,788 $1.09 Million
Q3 2023

Oct 25, 2023

BUY
$218.65 - $271.46 $50,289 - $62,435
230 Added 6.85%
3,588 $964,000
Q2 2023

Jul 26, 2023

SELL
$214.27 - $253.37 $93,635 - $110,722
-437 Reduced 11.52%
3,358 $746,000
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $7,328 - $9,312
-32 Reduced 0.84%
3,795 $997,000
Q2 2022

Aug 01, 2022

SELL
$230.71 - $256.74 $33,683 - $37,484
-146 Reduced 3.67%
3,827 $931,000
Q4 2021

Feb 01, 2022

BUY
$198.88 - $227.6 $41,764 - $47,796
210 Added 5.58%
3,973 $894,000
Q3 2021

Oct 27, 2021

SELL
$212.27 - $248.7 $134,791 - $157,924
-635 Reduced 14.44%
3,763 $800,000
Q2 2021

Jul 30, 2021

BUY
$233.58 - $259.14 $122,395 - $135,789
524 Added 13.53%
4,398 $1.07 Million
Q1 2021

May 05, 2021

BUY
$221.91 - $258.6 $77,668 - $90,510
350 Added 9.93%
3,874 $964,000
Q4 2020

Feb 10, 2021

SELL
$216.38 - $257.67 $25,100 - $29,889
-116 Reduced 3.19%
3,524 $810,000
Q2 2020

Jul 06, 2020

SELL
$197.81 - $242.74 $39,166 - $48,062
-198 Reduced 5.16%
3,640 $859,000
Q1 2020

Jun 02, 2020

SELL
$182.24 - $241.7 $2.74 Million - $3.64 Million
-15,050 Reduced 79.68%
3,838 $778,000
Q4 2019

Jan 22, 2020

SELL
$189.21 - $243.2 $91,956 - $118,195
-486 Reduced 2.51%
18,888 $4.55 Million
Q3 2019

Nov 05, 2019

BUY
$174.11 - $208.62 $160,877 - $192,764
924 Added 5.01%
19,374 $3.75 Million
Q2 2019

Jul 26, 2019

SELL
$166.7 - $195.41 $17,336 - $20,322
-104 Reduced 0.56%
18,450 $3.4 Million
Q1 2019

May 03, 2019

SELL
$180.87 - $203.88 $43,589 - $49,135
-241 Reduced 1.28%
18,554 $3.53 Million
Q4 2018

Jan 25, 2019

SELL
$178.4 - $208.25 $72,430 - $84,549
-406 Reduced 2.11%
18,795 $3.66 Million
Q3 2018

Oct 18, 2018

SELL
$185.29 - $208.89 $64,295 - $72,484
-347 Reduced 1.78%
19,201 $3.98 Million
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $36,863 - $41,405
-222 Reduced 1.12%
19,548 $3.61 Million
Q1 2018

May 02, 2018

SELL
$169.43 - $198.0 $864,093 - $1.01 Million
-5,100 Reduced 20.51%
19,770 $3.37 Million
Q4 2017

Feb 07, 2018

SELL
$168.79 - $188.59 $117,646 - $131,447
-697 Reduced 2.73%
24,870 $4.33 Million
Q3 2017

Oct 16, 2017

BUY
$167.29 - $191.0 $4.28 Million - $4.88 Million
25,567
25,567 $4.77 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Groesbeck Investment Management Corp Portfolio

Follow Groesbeck Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groesbeck Investment Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Groesbeck Investment Management Corp with notifications on news.